The aim of this work was to describe clinical features among five patients with concomitant <i>SCN2A</i> gene variants and cryptogenic epileptic syndromes, thus expanding the <i>SCN2A</i> spectrum of phenotypic heterogeneity. Here, SCN2A is linked to epilepsy syndrome.